Aktis Oncology, Inc. (AKTS) vs MannKind Corporation (MNKD)
Aktis Oncology, Inc. and MannKind Corporation are both Biotechnology companies. Aktis Oncology, Inc. and MannKind Corporation are of similar size ($1.1B and $1.1B). MannKind Corporation has the higher net margin (−11.1% vs −782.0%) and the higher return on invested capital (2.36% vs 0.00%). Across the 15 metrics below, MannKind Corporation leads on 11 and Aktis Oncology, Inc. on 4.
Valuation
Profitability
| Metric | AKTS | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.39% | 65.16% |
| Operating margin | (939.13%) | 2.34% | 0.00% |
| Net margin | (781.95%) | (11.08%) | 0.00% |
| Free cash flow margin | (1,442.91%) | (4.61%) | 0.00% |
| Return on equity | (34.45%) | 71.36% | (57.72%) |
| Return on assets | (27.09%) | (7.62%) | (49.22%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack